Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Scientific D. LSE:SDI London Ordinary Share GB00B3FBWW43 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 35.50p 71,392 08:00:00
Bid Price Offer Price High Price Low Price Open Price
35.00p 36.00p 35.50p 35.50p 35.50p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Electronic & Electrical Equipment 1.45 1.71 1.81 19.6 31.5

Scientific Digital Imaging (SDI) Latest News

More Scientific Digital Imaging News
Scientific Digital Imaging Takeover Rumours

Scientific Digital Imaging (SDI) Share Charts

1 Year Scientific Digital Imaging Chart

1 Year Scientific Digital Imaging Chart

1 Month Scientific Digital Imaging Chart

1 Month Scientific Digital Imaging Chart

Intraday Scientific Digital Imaging Chart

Intraday Scientific Digital Imaging Chart

Scientific Digital Imaging (SDI) Discussions and Chat

Scientific Digital Imaging Forums and Chat

Date Time Title Posts
11/12/201820:39SDI - Global & Niche imaging portfolio for scientific & medical users1,389
12/7/201706:40Scientific Digital Imaging - with charts & news19
08/7/201716:53Scientific Digital Imaging18

Add a New Thread

Scientific Digital Imaging (SDI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-12-11 16:26:2535.9015,0005,385.00O
2018-12-11 16:22:1635.904,7071,689.81O
2018-12-11 13:15:5235.006,8282,389.80O
2018-12-11 11:40:0935.5010,0003,550.00O
2018-12-11 11:39:0035.558,0002,844.00O
View all Scientific Digital Imaging trades in real-time

Scientific Digital Imaging (SDI) Top Chat Posts

Scientific Digital Imaging Daily Update: Scientific D. is listed in the Electronic & Electrical Equipment sector of the London Stock Exchange with ticker SDI. The last closing price for Scientific Digital Imaging was 35.50p.
Scientific D. has a 4 week average price of 34p and a 12 week average price of 34p.
The 1 year high share price is 46.25p while the 1 year low share price is currently 22.75p.
There are currently 88,840,194 shares in issue and the average daily traded volume is 227,199 shares. The market capitalisation of Scientific D. is £31,538,268.87.
rivaldo: It's ironic that SDI's share price has fallen just as sector comparator JDG jumps after reporting on Wednesday that trading is ahead of expectations. There should be some encouragement from a fellow scientific instrument group reporting such strong trading.
hastings: Here we go, hopefully of interest. The perfect morning for a bike ride to the other side of Cambridge, where I duly arrived with a good 15 minutes to spare. On my arrival, it was good to meet two other private investors who had travelled to the AGM where we were soon joined by the SDI people who had just concluded a board meeting. Fortunately we convened in a room large enough to seat everyone which included representatives from each arm of the Group, including the chap who assists Mike Creedon and Ken Ford in identifying potential acquisitions, (he has in the past worked with Judges too). After the formal business Ken Ford opened the meeting up to questions which saw each of us putting forward various points that also carried on after the meeting was concluded. Rather than say who asked what, I'll just give a summary although given that we weren't together the whole time, there may be one or two aspects that I wasn't privy to. The acquisition was not surprisingly raised and they agreed that it was a good one executed at a good price for SDI. The background is that Applied Thermal Control which is also based in Leicestershire was already aware of Fistreem and had raised its presence to the board. It appears the main player of the Fistreem business is in his seventies now and was looking to exit. No doubt the various pre-nuptials were played out before a tying of the knot, where now complete, there would certainly appear to be potential in terms of synergies going forward as it does indeed look another good fit. In terms of a positive contribution to the Group, Fistreem will be wholly earning enhancing in its first full year, the FD John Abell pointing out that the performance in the remainder of the current year will include acquisition costs, although there will be a small positive benefit. Expanding on the buy model, it was pointed out to us that SDI has a strict criteria for bolt-on-buys particularly where Mike Creedon is concerned, who is keen to not overpay, rather secure a deal at a good price to the company and shareholders. There are it appears plenty of potential targets and SDI has a strong pipeline of these in what is a very fragmented space, many smaller players being out there which wouldn't appeal to the bigger boys, but do make for ideal earning enhancing additions. There have however been a couple of instances where SDI has walked away, which is no bad thing in the grand scale of things. With the banking facility in place (which could be upped if they chose) and positive cash on the balance sheet they can do two or three more similar purchases with this mix, although further ahead they wouldn't rule out a placing to support something larger. On this aspect Ken Ford said that they are extremely mindful of not biting off more than they can chew, so I don't think SDI would ever over reach, more a case of continuing the current way of doing things. There is certainly nothing planned in terms of a placing at present, but both Ken and Mike said that if they were to undertake a raise again in the future, this time there would be some provision in place for private investors to take part alongside the Institutions the latter of which would readily support the process. The various aspects of the company are pleasingly all going well as per the TU, but we also heard more close at hand from a couple of those. ATIK was represented by Steve Chambers who filled us in on the purchase made earlier this year of assets and IP of Quantum Scientific Imaging. The background here was that Quantum's owner had passed away which left the business seemingly without direction thus opening the door for ATIK to acquire the brand. Chambers pointed out that Quantum had a good reputation and served the higher end of the market and now sits nicely alongside its own products. The real positive though is that through Quantum the profile of ATIK's offerings have been raised positively providing for new or expanded markets. Next up for a word was Kate George sales and technical director at Synoptics who filled us in on ProReveal's progress. As far as the NHS goes she says ten per-cent of the total Hospitals that should be conforming with DOH guidelines have now adopted the system and they continue to push with the remainder, but it is difficult dealing with the NHS. Perhaps more positively there are talks now with the actual washing machine manufacturers which with a more recent development has seen a player focused on the cleaning of endoscopes improving the cleaning process which would as part of its operation include ProReveal. Kate also confirmed that the wider Synoptics division is now into a second year of profitability having been for so long operating at break even. As a company, Ken Ford confirmed that they will only release news when it is required or noteworthy, adding that they are not into trying to fluff the share price up. He's also very relaxed about the latter at present and is intent on building the business to a substantial size, much greater than the current market cap. John Abell added that since he came on board he's been impressed having worked in much bigger organisations and wonders just how Mike managed to do so much on his own, which I think is what many of us have thought, so a good addition to my mind. Going forward, Abell talks of the company now needing to get the earnings per share up, which would then see the share price follow to the benefit of investors. Potential dividends were also raised and Ken Ford said this had been discussed and could be implemented in the future for a progressive path without affecting the buy-build strategy. He does point out that high cover would be a prerequisite and talks of 4-5x being the marker. All in all a good hour well spent where it was nice to be warmly welcomed alongside catching up with a couple of very nice fellow investors.
rivaldo: Cheers hastings, a terrific and very thorough write-up. Nice conclusion which shows just how good a job the management are doing: "There is also the possibility of a dividend being installed further down the line, which given the boards tone in the past would suggest a progressive path being followed once instigated. No doubt as the year progresses we will hear more from SDI, either on the acquisition front, new product launches or possibly another upgrade, any of which could provide for further momentum in the share price. Having just four years back been seen as an AIM basket case at break even with a market cap of just a few million SDI is now looking like a serious ambitious and growing operation that is now raising more than just a few eyebrows."
hastings: Write up from the results for interest
hastings: Very happy with SDI's performance.When I first met Mike and Ken the share price was on its knees as they outlined their strategy for growth. Four years on they've delivered handsomely and look set to accelerate that.Spoken with both this morning and will endeavour to provide a write up in due course.
pireric: ProReveal is interesting. Has come a long way compared to back 3-4 years ago when I looked at it and attributed a value of zero Still, not really putting any true value into it or for my expectations as quite frankly no idea what it's worth. Put it another way, if they came out tomorrow and said they were discontinuing ProReveal, I suspect the share price might fall 2-3p? Anyone already crunched the numbers on what sort of realistic upside could be on offer?
mr doughnut1: Mentioned in this weeks IC (hard copy) Article -' 7 steps to healthy profits' In the table at the end of the article they divide the health care market into five categories - 'drug discovery, tools and services, primary and emergency care, hospital equipment and animal health - and picked out the metrics that could help identify the companies with the greatest potential.' SDI comes in a number four under hospital equipment. It is listed as having A market cap of 31.82m. A one year percentage share price change of + 36.54%. The number of products less than 20 Operating markets listed as UK, Europe, America and Asia A 'Free cash flow yield of 2.03 percent' The metrics the have used are Revenue quality - companies with more than one product. Low risk - those with operations in more that one market. Financially stable - cash generative. It sounds like there will be follow up articles in 'our new Alpha series in which we will be delving into the investment case of a number of companies, taking a closer look at the science, the financial position and management team to decide wether the shares are worth a punt.' I know there are a lot of investors who don't rate the IC, but in my view anything that raises the profile of SDI can only be a good thing. I bought in following David Tilston's purchase of 45000 shares on the 5th of Feb at 31.46 pence. It wasn't a large purchase but, I am a big fan of non-executive director purchases. Non exec's aren't directly involved in the day to day running of a company but maintain a broad overview of exactly what is going on, and the direction of travel. There are some really interesting posts on this thread keep it up.
fillspectre: We seem to be in a share price drift downwards phase on very little activity. I suspect this will be the case until we hear of the next acquisition. We've been put on notice there is likely to be another one. Fils
fillspectre: Rivaldo - Let us hope Universal's success continues with them picking a winner with SDI. A 5.2% stake is not inconsiderable. Any ideas who they acquired this from? A very positive development and potentially underpins the share price at its current level. Fils
mudbath: "Whilst under the terms of the Bridge Facility the funding available under that facility is only available for two months following the Acquisition, the Directors believe that, subject to agreement on the terms, the Company would be able to refinance the Bridge Facility so as to enable the amount outstanding under the Bridge Facility to be repaid over the medium term. There can, however, be no guarantee that such a refinancing would be available, leaving the Company in default, and the terms of any such refinancing, if available, may be on terms that are more onerous than the terms of the Term Loan Facility." The date for any potential default has now passed. On the basis that the bridge has now been refinanced over a medium term,I am of the opinion that the SDI share price might now start to edge upwards,reflecting the possibility of the Company being able to surprise the market,on the upside,come the next RNS.
Scientific Digital Imaging share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181212 05:55:41